Market Overview:
The Asia Pacific dry eye syndrome market is expected to exhibit a CAGR of X% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Dry eye syndrome, or keratoconjunctivitis sicca (KCS), is a chronic disorder that occurs due to the lack of adequate moisture or lubrication on the surface of the eyes. It is a medical ailment characterized by various symptoms, such as aching, discomfort, burning, pain, redness, photophobia and irritation in the eyes. Dry eye syndrome is caused due to multiple factors, such as allergies, menopause, vitamins deficiency, laser surgery, autoimmune diseases and extensive screen time. It can be treated by administering artificial tears, surgeries, medications and lacrimal plugs. It can also be prevented by wearing wraparound sunglasses or other protective eyewear.
www.imarcgroup.com
Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.
The growth in the Asia pacific dry eye syndrome market can be attributed to the increasing environmental pollution levels in the region. Dry eye syndrome is widely associated with prolonged exposure to dust, wind and dry climatic conditions that increases tear evaporation resulting in dry eye syndrome. In addition to this, the increasing utilization of laptops, smartphones and television among the masses leading to prolonged and excessive screen time is impacting the occurrence of the syndrome. Moreover, the utilization of secretagogues for the treatment of dry eye syndrome is providing a thrust to the market growth. It is widely used for stimulating the production of mucin and tears in the eyes. In line with this, the rising geriatric population prone to chronic eye-related diseases is positively impacting the market growth. Dry eye syndrome is also associated with various medical disorders, such as diabetes, Sjogren's syndrome, arthritis, thyroid disorders, lupus and scleroderma, which is highly prevalent in the elderly patients. Other factors, including the lack of physical activities among the masses resulting in increasing oxidative stress, along with the increasing healthcare expenditure capacities of the consumers, are creating a positive outlook for the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the Asia Pacific dry eye syndrome market, along with forecasts at the country and regional level from 2022-2027. Our report has categorized the market based on disease type, drug type, product and distribution channel.
Breakup by Disease Type:
www.imarcgroup.com
Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.
- Evaporative Dry Eye Syndrome
- Aqueous Dry Eye Syndrome
Breakup by Drug Type:
- Anti-inflammatory Drugs
- Lubricant Eye Drops
- Autologous Serum Eye Drops
Breakup by Product:
- Liquid Drops
- Gel
- Liquid Wipes
- Eye Ointment
- Others
Breakup by Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Breakup by Country:
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
Report Coverage:
| Report Features |
Details |
|---|
| Base Year of the Analysis |
2021 |
| Historical Period |
2016-2021 |
| Forecast Period |
2022-2027 |
| Units |
US$ Billion |
| Segment Coverage |
Disease Type, Drug Type, Product, Distribution Channel, Country |
| Countries Covered |
China, Japan, India, South Korea, Australia, Indonesia |
| Customization Scope |
10% Free Customization |
| Report Price and Purchase Option |
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499 |
| Post-Sale Analyst Support |
10-12 Weeks |
| Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the Asia Pacific dry eye syndrome market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the Asia Pacific dry eye syndrome market?
- What are the key regional markets?
- What is the breakup of the market based on the disease type?
- What is the breakup of the market based on the drug type?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the distribution channel?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the Asia Pacific dry eye syndrome market and who are the key players?
- What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Asia Pacific Dry Eye Syndrome Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Disease Type
6.1 Evaporative Dry Eye Syndrome
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Aqueous Dry Eye Syndrome
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Drug Type
7.1 Anti-inflammatory Drugs
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Lubricant Eye Drops
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Autologous Serum Eye Drops
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Product
8.1 Liquid Drops
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Gel
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Liquid Wipes
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Eye Ointment
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 Market Breakup by Distribution Channel
9.1 Hospital Pharmacies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Retail Pharmacies
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Online Pharmacies
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by Country
10.1 China
10.1.1 Market Trends
10.1.2 Market Breakup by Disease Type
10.1.3 Market Breakup by Drug Type
10.1.4 Market Breakup by Product
10.1.5 Market Breakup by Distribution Channel
10.1.6 Market Forecast
10.2 Japan
10.2.1 Market Trends
10.2.2 Market Breakup by Disease Type
10.2.3 Market Breakup by Drug Type
10.2.4 Market Breakup by Product
10.2.5 Market Breakup by Distribution Channel
10.2.6 Market Forecast
10.3 India
10.3.1 Market Trends
10.3.2 Market Breakup by Disease Type
10.3.3 Market Breakup by Drug Type
10.3.4 Market Breakup by Product
10.3.5 Market Breakup by Distribution Channel
10.3.6 Market Forecast
10.4 South Korea
10.4.1 Market Trends
10.4.2 Market Breakup by Disease Type
10.4.3 Market Breakup by Drug Type
10.4.4 Market Breakup by Product
10.4.5 Market Breakup by Distribution Channel
10.4.6 Market Forecast
10.5 Australia
10.5.1 Market Trends
10.5.2 Market Breakup by Disease Type
10.5.3 Market Breakup by Drug Type
10.5.4 Market Breakup by Product
10.5.5 Market Breakup by Distribution Channel
10.5.6 Market Forecast
10.6 Indonesia
10.6.1 Market Trends
10.6.2 Market Breakup by Disease Type
10.6.3 Market Breakup by Drug Type
10.6.4 Market Breakup by Product
10.6.5 Market Breakup by Distribution Channel
10.6.6 Market Forecast
10.7 Others
10.7.1 Market Trends
10.7.2 Market Breakup by Disease Type
10.7.3 Market Breakup by Drug Type
10.7.4 Market Breakup by Product
10.7.5 Market Breakup by Distribution Channel
10.7.6 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Policy and Regulatory Landscape
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
List of Figures
Figure 1: Asia Pacific: Dry Eye Syndrome Market: Major Drivers and Challenges
Figure 2: Asia Pacific: Dry Eye Syndrome Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Asia Pacific: Dry Eye Syndrome Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Asia Pacific: Dry Eye Syndrome Market: Breakup by Disease Type (in %), 2021
Figure 5: Asia Pacific: Dry Eye Syndrome Market: Breakup by Drug Type (in %), 2021
Figure 6: Asia Pacific: Dry Eye Syndrome Market: Breakup by Product (in %), 2021
Figure 7: Asia Pacific: Dry Eye Syndrome Market: Breakup by Distribution Channel (in %), 2021
Figure 8: Asia Pacific: Dry Eye Syndrome Market: Breakup by Country (in %), 2021
Figure 9: Asia Pacific: Dry Eye Syndrome (Evaporative) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Asia Pacific: Dry Eye Syndrome (Evaporative) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Asia Pacific: Dry Eye Syndrome (Aqueous) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Asia Pacific: Dry Eye Syndrome (Aqueous) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Asia Pacific: Dry Eye Syndrome (Anti-inflammatory Drugs) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Asia Pacific: Dry Eye Syndrome (Anti-inflammatory Drugs) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Asia Pacific: Dry Eye Syndrome (Lubricant Eye Drops) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Asia Pacific: Dry Eye Syndrome (Lubricant Eye Drops) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Asia Pacific: Dry Eye Syndrome (Autologous Serum Eye Drops) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Asia Pacific: Dry Eye Syndrome (Autologous Serum Eye Drops) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Asia Pacific: Dry Eye Syndrome (Liquid Drops) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Asia Pacific: Dry Eye Syndrome (Liquid Drops) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Asia Pacific: Dry Eye Syndrome (Gel) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Asia Pacific: Dry Eye Syndrome (Gel) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Asia Pacific: Dry Eye Syndrome (Liquid Wipes) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Asia Pacific: Dry Eye Syndrome (Liquid Wipes) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Asia Pacific: Dry Eye Syndrome (Eye Ointment) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Asia Pacific: Dry Eye Syndrome (Eye Ointment) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Asia Pacific: Dry Eye Syndrome (Other Products) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Asia Pacific: Dry Eye Syndrome (Other Products) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Asia Pacific: Dry Eye Syndrome (Hospital Pharmacies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Asia Pacific: Dry Eye Syndrome (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Asia Pacific: Dry Eye Syndrome (Retail Pharmacies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Asia Pacific: Dry Eye Syndrome (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Asia Pacific: Dry Eye Syndrome (Online Pharmacies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Asia Pacific: Dry Eye Syndrome (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: China: Dry Eye Syndrome Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: China: Dry Eye Syndrome Market: Breakup by Disease Type (in %), 2021
Figure 37: China: Dry Eye Syndrome Market: Breakup by Drug Type (in %), 2021
Figure 38: China: Dry Eye Syndrome Market: Breakup by Product (in %), 2021
Figure 39: China: Dry Eye Syndrome Market: Breakup by Distribution Channel (in %), 2021
Figure 40: China: Dry Eye Syndrome Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: Japan: Dry Eye Syndrome Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: Japan: Dry Eye Syndrome Market: Breakup by Disease Type (in %), 2021
Figure 43: Japan: Dry Eye Syndrome Market: Breakup by Drug Type (in %), 2021
Figure 44: Japan: Dry Eye Syndrome Market: Breakup by Product (in %), 2021
Figure 45: Japan: Dry Eye Syndrome Market: Breakup by Distribution Channel (in %), 2021
Figure 46: Japan: Dry Eye Syndrome Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: India: Dry Eye Syndrome Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: India: Dry Eye Syndrome Market: Breakup by Disease Type (in %), 2021
Figure 49: India: Dry Eye Syndrome Market: Breakup by Drug Type (in %), 2021
Figure 50: India: Dry Eye Syndrome Market: Breakup by Product (in %), 2021
Figure 51: India: Dry Eye Syndrome Market: Breakup by Distribution Channel (in %), 2021
Figure 52: India: Dry Eye Syndrome Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: South Korea: Dry Eye Syndrome Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: South Korea: Dry Eye Syndrome Market: Breakup by Disease Type (in %), 2021
Figure 55: South Korea: Dry Eye Syndrome Market: Breakup by Drug Type (in %), 2021
Figure 56: South Korea: Dry Eye Syndrome Market: Breakup by Product (in %), 2021
Figure 57: South Korea: Dry Eye Syndrome Market: Breakup by Distribution Channel (in %), 2021
Figure 58: South Korea: Dry Eye Syndrome Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Australia: Dry Eye Syndrome Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Australia: Dry Eye Syndrome Market: Breakup by Disease Type (in %), 2021
Figure 61: Australia: Dry Eye Syndrome Market: Breakup by Drug Type (in %), 2021
Figure 62: Australia: Dry Eye Syndrome Market: Breakup by Product (in %), 2021
Figure 63: Australia: Dry Eye Syndrome Market: Breakup by Distribution Channel (in %), 2021
Figure 64: Australia: Dry Eye Syndrome Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Indonesia: Dry Eye Syndrome Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Indonesia: Dry Eye Syndrome Market: Breakup by Disease Type (in %), 2021
Figure 67: Indonesia: Dry Eye Syndrome Market: Breakup by Drug Type (in %), 2021
Figure 68: Indonesia: Dry Eye Syndrome Market: Breakup by Product (in %), 2021
Figure 69: Indonesia: Dry Eye Syndrome Market: Breakup by Distribution Channel (in %), 2021
Figure 70: Indonesia: Dry Eye Syndrome Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Others: Dry Eye Syndrome Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: Others: Dry Eye Syndrome Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Asia Pacific: Dry Eye Syndrome Industry: SWOT Analysis
Figure 74: Asia Pacific: Dry Eye Syndrome Industry: Value Chain Analysis
Figure 75: Asia Pacific: Dry Eye Syndrome Industry: Porter’s Five Forces Analysis
List of Tables
Table 1: Asia Pacific: Dry Eye Syndrome Market: Key Industry Highlights, 2021 and 2027
Table 2: Asia Pacific: Dry Eye Syndrome Market Forecast: Breakup by Disease Type (in Million US$), 2022-2027
Table 3: Asia Pacific: Dry Eye Syndrome Market Forecast: Breakup by Drug Type (in Million US$), 2022-2027
Table 4: Asia Pacific: Dry Eye Syndrome Market Forecast: Breakup by Product (in Million US$), 2022-2027
Table 5: Asia Pacific: Dry Eye Syndrome Market Forecast: Breakup by Distribution Channel (in Million US$), 2022-2027
Table 6: Asia Pacific: Dry Eye Syndrome Market Forecast: Breakup by Country (in Million US$), 2022-2027
Table 7: Asia Pacific: Dry Eye Syndrome Market: Competitive Structure
Table 8: Asia Pacific: Dry Eye Syndrome Market: Key Players